Potential pharmacological uses of chalcones: a patent review (from June 2011 – 2014)

Bibliography

• Di Carlo G, Mascolo N, Izzo AA, et al. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 1999;65:337-53
   PubMed Web of Science ®Google Scholar
• Sahu NK, Balbhadra SS, Choudhary J, et al. Exploring pharmacological significance of chalcone scaffold: a review. Curr Med Chem 2012;19(2):209-25
   PubMed Web of Science ®Google Scholar
• Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007;42:125-37
   PubMed Web of Science ®Google Scholar
• Lawrence NJ, Patterson RP, Ooi LL, et al. Effects of alpha-substitutions on structure and biological activity of anticancer chalcones. Bioorg Med Chem Lett 2006;16:5844-8
   PubMed Web of Science ®Google Scholar
• Bukhari SNA, Jasamai M, Jantan I, et al. Reviews of methods and various catalysts used for chalcone synthesis. Mini-Rev Org Chem 2013;10:73-83
   Web of Science ®Google Scholar
• Guida A, Lhouty MH, Tichit D, et al. Hydrotalcites as base catalysts. Kinetics of Claisen-Schmidt condensation, intramolecular condensation of acetonylacetone and synthesis of chalcone. Appl Catal A 1997;164:251-64
   Web of Science ®Google Scholar
• Mukaiyama T. The directed aldol reaction. Org React 1982;28:203-331
   Web of Science ®Google Scholar
• Eddarir S, Cotelle N, Bakkour Y, et al. An efficient synthesis of chalcones based on the Suzuki reaction. Tetrahedron Lett 2003;44:5359-63
   Web of Science ®Google Scholar
• Al-Masum M, Ng E, Wai M. Palladium-catalyzed direct cross-coupling of potassium styryltrifluoroborates and benzoyl chlorides–a one step method for chalcone synthesis. Tetrahedron Lett 2011;52:1008-10
   Web of Science ®Google Scholar
• Zou G, Guo J, Wang Z, et al. Heck-type coupling vs. conjugate addition in phosphine-rhodium catalyzed reactions of aryl boronic acids with alpha,beta-unsaturated carbonyl compounds: a systematic investigation. Dalton Trans 2007;28:3055-64
   Google Scholar
• Bohm A. Introduction to flavonoids. Harwood Academic Pub; London: 1998
   Google Scholar
• Kumar A, Sharma S, Tripathi VD, et al. Synthesis of chalcones and flavanones using Julia–Kocienski olefination. Tetrahedron 2010;66:9445-9
   Web of Science ®Google Scholar
• Singh P, Anand A, Kumar V. Recent developments in biological activities of chalcones: a mini review. Eur J Med Chem 2014;85C:758-77
   Google Scholar
• Singh P, Raj R, Kumar V, et al. 1,2,3-Triazole tethered beta-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation. Eur J Med Chem 2012;47:594-600
   PubMed Web of Science ®Google Scholar
• Mai CW, Yaeghoobi M, Rahman NA, et al. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure–activity relationship analysis and regulation of apoptotic proteins. Eur J Med Chem 2014;77:378-87
   PubMed Web of Science ®Google Scholar
• Winter E, Pizzol CD, Locatelli C, et al. In vitro and in vivo effects of free and chalcones-loaded nanoemulsions: insights and challenges in targeted cancer chemotherapies. Int J Environ Res Public Health 2014;11(10):10016-35
   PubMed Web of Science ®Google Scholar
• Pérez-Cruz F, Vazquez-Rodriguez S, Matos MJ, et al. Synthesis and electrochemical and biological studies of novel coumarin-chalcone hybrid compounds. J Med Chem 2013;56(15):6136-45
   PubMed Web of Science ®Google Scholar
• Aly M, Fodah H, Saleh SY. Antiobesity, antioxidant and cytotoxicity activities of newly synthesized chalcone derivatives and their metal complexes. Eur J Med Chem 2014;76:517-30
   PubMed Web of Science ®Google Scholar
• Vazquez-Rodriguez S, Matos MJ, Santana L, et al. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists. J Pharm Pharmacol 2013;65(5):697-703
   PubMed Web of Science ®Google Scholar
• Sinha S, Medhi B, Sehgal R. Chalcones as an emerging lead molecule for antimalarial therapy: a review. J Modern Med Chem 2013;1:64-77
   Google Scholar
• Guantai EM, Ncokazi K, Egan TJ, et al. Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies. J Med Chem 2011;54:3637-49
   PubMed Web of Science ®Google Scholar
• Yin BT, Yan CY, Peng XM, et al. Synthesis and biological evaluation of alpha-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albumin. Eur J Med Chem 2014;71:148-59
   PubMed Web of Science ®Google Scholar
• Sharma H, Patil S, Sanchez TW, et al. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors. Bioorg Med Chem 2011;19:2030-45
   PubMed Web of Science ®Google Scholar
• Fatima S, Sharma A, Saxena R, et al. One pot efficient diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-HIV agents. Eur J Med Chem 2012;55:195-204
   PubMed Web of Science ®Google Scholar
• Anthwal A, Rajesh UC, Rawat MS, et al. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis. J Med Chem 2014;79:89-94
   Web of Science ®Google Scholar
• Bello ML, Chiaradia LD, Dias LR, et al. Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure–activity relationship (SAR). Bioorg Med Chem Lett 2011;19:5046-52
   Google Scholar
• Zhengzhou University. Method for extracting active ingredients from Chinese medicine Dalbergia and their application as cardiovascular agent. CN102119957; 2011
   Google Scholar
• Paek KS. Dalbergia odorifera extracts and compounds separated therefrom for preventing skin aging. WO2011108821
   Google Scholar
• Hanbul Cosmetics Co Ltd. External skin care agent containing glycyrrhizae radix extract with increased isoliquiritigenin content. KR20120081289
   Google Scholar
• Hanbul Cosmetics Co Ltd. Isoliquiritigenin for improving hypnotic effect. KR20120078898
   Google Scholar
• Shandong Eye Inst. Eye drops of isoliquiritigenin and its preparation method. CN102488674; 2012
   Google Scholar
• Capital Medical University. Application of isoliquiritigenin in medicine for preventing and/or treating cardio-cerebrovascular disease. CN102247339; 2011
   Google Scholar
• Adbiotech Co Ltd. Method for extracting functional components from Glycyrrhiza inflate. KR0107652; 2012
   Google Scholar
• Dermatologiques D Uriage Lab. Cosmetic composition for the treatment of oily skin. FR2997626; 2014
   Google Scholar
• Beiersdorf Ag. Hair styling formulation for generating flexible hold by application of licochalcone A or aqueous extract from Radix Glycyrrhizae inflatae, containing licochalcone A. DE102012213938; 2014
   Google Scholar
• Beiersdorf Ag. Skin friendly active ingredient combination against acne comprising 1,2-decanediol, Licochalcone A, and carnitine. WO117126; 2011
   Google Scholar
• Shanghai Zhenxin Chemical Co Ltd. Clary sage oil-containing cosmetic astringent. CN103340781; 2013
   Google Scholar
• Shanghai Zhenxin Chemical Co Ltd. Sanguisorba officinalis extract-containing toner. CN103340794; 2013
   Google Scholar
• Shanghai Zhenxin Chemical Co Ltd. Matricaria essential oil bath salt. CN103340774; 2013
   Google Scholar
• Shanghai Bafang Fine Chemical. Bath salt containing rose essential oils. CN103284917; 2013
   Google Scholar
• University-Industry Cooperation Group of Kyung Hee. Novel uses of licochalcone A. WO144854; 2012
   Google Scholar
• University-Industry Cooperation Group of Kyung Hee. Licochalcone A for the treatment of metabolic disorders. EP2700402; 2011
   Google Scholar
• Inst Radiation Med Amms Pla. Application of licochalcone A as antiviral agent. CN103405402; 2013
   Google Scholar
• Lotte Co. Ltd. Deodorant composition containing extracts of Angelica keiskei for prevention of mouth odor. JP067585; 2013
   Google Scholar
• Nanjing Zelang Agri Dev Co Ltd. Method for preparing xanthoangelol from Angelica keiskei. CN102826986; 2012
   Google Scholar
• Suzhou Baozetang Medical Tech. Extraction and purification of chalcones from Angelica keisk. CN102911032; 2013
   Google Scholar
• Fancl Corp Keio Gijuku. Melanin formation inhibitors and skin-lightening agents containing isobavachalcone. JP184401; 2011
   Google Scholar
• Tianjin University of Traditional Chinese Medicine. Application of isobavachalcone for treating neuritic diseases. CN102772393; 2012
   Google Scholar
• Fancl Corp. Cholesterol absorption inhibitor containing Psoralea corylifolia. JP216648; 2013
   Google Scholar
• Shenyang Chemical Technology University. Psoralen chalcone soluble liquid, its preparation method and application for controlling plant fungal and viral diseases. CN102893986; 2013
   Google Scholar
• Hunan Sanwei Biolog Technology Co Ltd. A method of extracting xanthohumol from hops. CN103524321; 2014
   Google Scholar
• Weluga Pharm Anstalt. Pharmaceutical composition with olive extract (hydroxytyrosol) and hop extract (xanthohumol) for intranasal application. WO153647; 2011
   Google Scholar
• Ocean University China. Application of xanthohumol in preparation of medicine for inhibiting activity of alpha-glucosidase or in health product. CN103735537; 2014
   Google Scholar
• Jung HG, Lee GY, Hwang YP, et al. Xanthohumol for treating and preventing osteoporosis. KR0120545; 2012
   Google Scholar
• Qimin L. Method for improving water solubility of xanthohumol. CN102309766; 2012
   Google Scholar
• Yan J. Application of nardoaristolones A in preparing medicine for treatment of gastric cancer. CN103462955; 2013
   Google Scholar
• Liu M. Application of nardoaristolones A to manufacture of the medicine for treating endometrium cancer. CN103405406; 2013
   Google Scholar
• Zhang Y. Application of nardoaristolones A in preparation of drugs for treating rheumatoid arthritis. CN103393635; 2013
   Google Scholar
• Yan J. Application of nardoaristolone A in preparation of a medicament for promotion of small bowel peristalsis. CN103340848; 2013
   Google Scholar
• Fang Z. Application of nardoaristolones A in preparation of antitubercular drugs. CN103315991; 2013
   Google Scholar
• E.I. du Pont de Nemours and Co. Method for preparing 3-trifluoromethyl chalcones. US155617;2014
   Google Scholar
• Si Chuan University. (E)-1-[8-(5-methoxyl-2,2-dimethyl-2H-benzopyranyl)]-3-(4-methoxyphenyl)-2-propylene-1-ketone and analogs thereof, as well as preparation method and use thereof. WO163835; 2013
   Google Scholar
• National University of Singapore. Chalcone structure fluorescence dye for embryonic stem cell probe. WO026886; 2012
   Google Scholar
• Anhui University of Technology. A process preparing chalcones using polysulfonate ionic liquids as catalysts. CN103193607; 2013
   Google Scholar
• Universidad de Extremadura. Empleo de un catalizador heterogéneo ácido en la síntesis de cetonas alfa,beta-insaturadas a partir de aldehídos y cetonas. ES2395061; 2013
   Google Scholar
• Shihezi University. Microwave-assisted phase transfer catalysis as synthetic method of heterocyclic ring-containing chalcone derivatives. CN103408494; 2013
   Google Scholar
• Centre National De La Recherche Scientifique. Use of certain metal-accumulating plants for the performance of organic chemistry reactions. WO150197; 2013
   Google Scholar
• Nanjing University of Science and Technology. Method for preparing chalcones by fluorous biphasic catalysis with fluoride-free solvent. CN102850202; 2013
   Google Scholar
• Yunnan University. Liquid phase combinatorial method for synthesizing hydroxyflavone compound. CN102584765; 2012
   Google Scholar
• Chen D, Li Y. New method for synthesizing alpha,beta-unsaturated carbonyl compound via one-pot condensation. CN102786371; 2011
   Google Scholar
• Wenzhou University. Process for preparation of chalcone compounds. CN102775288; 2012
   Google Scholar
• Dalian University of Technology. Method for preparing alpha,beta-unsaturated carbonyl compound. CN102887807; 2013
   Google Scholar
• Dangar VR, Borkhataria KN, Shah VR. Synthesis, characterization and antimicrobial activity of pyrazoline & amino cyanopyridine derivatives of with vanillin. Sci Revs Chem Commun 2014;4(1):31-7
   Google Scholar
• Crawley LS, Fanshawe WJ. Neighboring group participation in cyclodehydration. A regiospecific isoxazole synthesis. J Heterocyclic Chem 1977;14:531-4
   Web of Science ®Google Scholar
• Taylor EC, Morrison RW. An unusual molecular rearrangement of an N-aminopyrimidine. J Org Chem 1967;32:2379-82
   PubMed Web of Science ®Google Scholar
• The Xinjing Technical Institute of Physics & Chemistry. Method for preparation of chalcone amide derivative and its application for treating vitiligo. CN103342653; 2013
   Google Scholar
• Aisa A, Niu C, Li G, Mai D. Chalcone benzothiazole amide derivatives as a tyrosinase agonist useful in treatment of vitiligo and their preparation. CN103360338; 2013
   Google Scholar
• Genfit. Improved preparation of chalcone derivatives. WO144579; 2011
   Google Scholar
• Xuzhou Ruisai Technology Industry Co., Ltd. Synthesis method for 3-phenyl-1-(4-methyl)phenyl-2-bromo-2-propylene-1-one. CN103664563; 2014
   Google Scholar
• University of Southern California. Direct trifluoromethylations using trifluoromethane. WO148772; 2012
   Google Scholar
• University of Central Florida Research Foundation. Heterogeneous metal-free catalyst. WO089537; 2014
   Google Scholar
• Symrise AG. Enzymatic biosynthesis of dihydrochalcones using chalcone isomerase and enoate reductase. US0045233; 2014
   Google Scholar
• Liuzhou Gaotong Food Chemicals Co., Ltd. Synthetic method of neohesperidin dihydrochalcone. CN103334119; 2013
   Google Scholar
• Gerke T, Kropf C, Huchel U, et al. Preparation of photolabile pro-fragrance materials. WO189646; 2013
   Google Scholar
• Guizhou University. Quinazolinyl-chalcone derivatives with high anti-plant virus activity and preparation method and application thereof in preparation of anti-plant virus pesticides. CN103755646; 2014
   Google Scholar
• Jiangsu Tiansheng Pharmaceutical Co Ltd. Resveratrol chalcone derivative and preparation method thereof. CN102093191; 2011
   Google Scholar
• Sun Yat-sen University. Preparation of chalcone derivatives with antitumor activity. CN103755732; 2014
   Google Scholar
• Zhejiang University. Chalcone compound containing piperazine ring useful in treatment of cancer and its preparation. CN103102331; 2013
   Google Scholar
• Nanjing University. Preparation of chalcone oxime derivatives useful as immunosuppressants. CN103102283; 2013
   Google Scholar
• Shenyang Pharmaceutical University. 2,2-Dimethylbenzopyran compounds, the preparation and application. CN102532082; 2012
   Google Scholar
• Shenyang Pharmaceutical University. Preparation of (E)-1-(5-substituted-2,2-dimethyl-2H-1-benzopyran-8-yl)-2-propen-1-one derivatives as antitumor agents. CN103382196; 2013
   Google Scholar
• Council for Scientific and Industrial Research. Preparation of coumarin and chalcone derivatives as anticancer agents. WO017454; 2012
   Google Scholar
• Ahmed K. Benzothiazole hybrids useful as anticancer agents and process for the preparation thereof. INDE00270; 2011
   Google Scholar
• Southern California University. Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer. WO016580; 2013
   Google Scholar
• Choong Ang Vaccine Laboratories Co., Ltd. Antiviral agents isolated from Cleistocalyx operculatus extra. WO023660; 2012
   Google Scholar
• Xiamen University. Preparation of chalcone derivatives and their application as anti-AIDS drug. CN103755541; 2014
   Google Scholar
• Yanbian University. 3-(Carboxylalkyl)rhodanine derivatives as antibacterial agents and their preparation, pharmaceutical compositions and use in the treatment of bacterial infection. CN102391262; 2012
   Google Scholar
• Colgate-Palmolive Co. Preparation and use of chalcones as enhancers of antimicrobial agents in treatment of oral microbial infections. WO075136; 2011
   Google Scholar
• Borate Hanumant Bapurao. Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation. INMU01750; 2011
   Google Scholar
• Kuwano T, Watanabe M, Murase T. Antiinflammatory agents, inflammatory cytokine expression inhibitors, and prostaglandin production inhibitors containing methoxychalcones. JP101329; 2014
   Google Scholar
• Sichuan University. (Benzopyranyl)chalcone compounds as inflammatory factor inhibitors and their preparation, pharmaceutical compositions and use in the treatment of inflammations. CN103382195; 2013
   Google Scholar
• Univ Konkuk Ind Coop Corp. Preparation of diphenylpropenone compound for the treatment of inflammatory disorder in the nervous system. WO065922; 2013
   Google Scholar
• Univ Ewha Ind Collaboration. Cinnamoylbenzene derivatives for treating and preventing inflammation or neurological disorders. KR0024011; 2013
   Google Scholar
• Piramal Life Sciences Ltd. Preparation of heterocyclic benzene compounds as cytokine inhibitors for treating inflammatory disorders. WO121505; 2011
   Google Scholar
• Wenzhou Medical College. Application of chalcone compounds in preparation of anti-inflammatory drugs and medicines for treating inflammation-associated diseases. CN102397269; 2012
   Google Scholar
• Yan J. Application of Nardoaristolone A in preparation of drugs for treating diabetes by reducing blood glucose. CN103301105; 2013
   Google Scholar
• Chengdu Institute of Biology, CAS. Alpha-Fluoro chalcone compounds useful in treatment of type II diabetes and their preparation. CN103254053; 2013
   Google Scholar
• Johns Hopkins University. Chalcone derivatives as Nrf2 activators, their preparation and therapeutic use. WO116362; 2012
   Google Scholar
• Chung Choon Hee. Curcumin derivative for treating diabetes complications. KR0134039; 2013
   Google Scholar
• Toray Industries. Tissue transglutaminase inhibitors containing chalcone derivatives (1-thienyl-3-phenyl-2-propen-1-ones) and anti-Alzheimer agents containing them. JP180955; 2013
   Google Scholar
• ICM - Institut du Cerveau et de la Moelle épinière. Composition for use in the treatment of neurodegenerative diseases with parkinsonian syndromes comprising an inhibitor of the COMT enzyme. WO139931; 2013
   Google Scholar